Processa Pharmaceuticals Names Russell L. Skibsted as Chief Financial Officer

Stock Information for Processa Pharmaceuticals Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Processa Pharmaceuticals Inc.

Processa Pharmaceuticals Announces First Patient Dosed in Phase 2 Clinical Trial of NGC-Cap in Metastatic Breast Cancer
Processa Pharmaceuticals to Participate in Investor and Industry Conferences During September
Processa Pharmaceuticals Provides Product Pipeline and Financial Update
Processa Pharmaceuticals Announces Positive Preclinical Data for NGC-Iri
Processa Pharmaceuticals Announces FDA Clearance of IND Application for a Phase 2 Clinical Trial of NGC-Cap in Breast Cancer
Processa Pharmaceuticals Announces Positive Efficacy Results from Preliminary Evaluation of Phase 1b Dose-escalating Trial with NGC-Cap in Gastrointestinal Cancer
Processa Pharmaceuticals to Participate in the EF Hutton Annual Global Conference
Processa Pharmaceuticals Names Dr. Steven Cha Senior Vice President of Clinical Research

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.